Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 27265347

Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Lancet
Publication date
2016 Jul 16
First author
Uesaka K

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2016 Jul 16;388(10041):214-5. doi: 10.1016/S0140-6736(16)30680-8.
    note
    Source null
    related pmid
    27265348
    relationship
    Comment in
  2. citation
    Chirurg. 2016 Oct;87(10):892. doi: 10.1007/s00104-016-0282-2.
    note
    Source null
    related pmid
    27586535
    relationship
    Comment in
  3. citation
    Turk J Gastroenterol. 2016 Sep;27(5):480-481. doi: 10.5152/tjg.2016.160005.
    note
    Source null
    related pmid
    27782903
    relationship
    Comment in

Authors and identifiers

  1. name
    Uesaka K
    type
    Author
  2. name
    Boku N
    type
    Author
  3. name
    Fukutomi A
    type
    Author
  4. name
    Okamura Y
    type
    Author
  5. name
    Konishi M
    type
    Author
  6. name
    Matsumoto I
    type
    Author
  7. name
    Kaneoka Y
    type
    Author
  8. name
    Shimizu Y
    type
    Author
  9. name
    Nakamori S
    type
    Author
  10. name
    Sakamoto H
    type
    Author
  11. name
    Morinaga S
    type
    Author
  12. name
    Kainuma O
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Uesaka K
    type
    Author
  2. name
    Boku N
    type
    Author
  3. name
    Fukutomi A
    type
    Author
  4. name
    Okamura Y
    type
    Author
  5. name
    Konishi M
    type
    Author
  6. name
    Matsumoto I
    type
    Author
  7. name
    Kaneoka Y
    type
    Author
  8. name
    Shimizu Y
    type
    Author
  9. name
    Nakamori S
    type
    Author
  10. name
    Sakamoto H
    type
    Author
  11. name
    Morinaga S
    type
    Author
  12. name
    Kainuma O
    type
    Author
bibliography ids
  1. nci-bib-177e5a969710a616e6654564
book metadata
content sha256
ad2ebe90245bcdba1b6dbbb208081921afd7895bd789ee8f4ef35d320b0dc1db
document type
citation
dois
  1. 10.1016/S0140-6736(16)30583-9
electronic publication date
display
2016 Jun 2
precision
day
year
2016
evidence scope
bibliographic_metadata_only
id
pubmed:27265347
immutable id
pubmed:27265347@ad2ebe90245bcdba1b6dbbb208081921afd7895bd789ee8f4ef35d320b0dc1db
journal
abbreviation
Lancet
issn electronic
1474-547X
issn print
0140-6736
issue
10041
name
Lancet (London, England)
nlm unique id
2985213R
pages
248-57
volume
388
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Lancet. 2016 Jul 16;388(10041):214-5. doi: 10.1016/S0140-6736(16)30680-8.
    note
    Source null
    related pmid
    27265348
    relationship
    Comment in
  2. citation
    Chirurg. 2016 Oct;87(10):892. doi: 10.1007/s00104-016-0282-2.
    note
    Source null
    related pmid
    27586535
    relationship
    Comment in
  3. citation
    Turk J Gastroenterol. 2016 Sep;27(5):480-481. doi: 10.5152/tjg.2016.160005.
    note
    Source null
    related pmid
    27782903
    relationship
    Comment in
outcomes validated
false
pmid
27265347
provenance
batch id
fe5a46c92522c34737e8
provider
NCBI PubMed ESummary
record sha256
9b09bbdcc5f9da4a201e783c61b21abe9e8e3f682c81929cee8bdc11c62ef9ac
response sha256
2c7bacd02d2ece3813daf1a0f92260c22884bd9268942fcca2088ab229bfb4d1
retrieved at
2026-09-09T23:47:17.939307+00:00
publication date
display
2016 Jul 16
precision
day
year
2016
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/27265347/
title
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01).

Preserved source evidence · Not medical advice